Sugemalimab approved to treat adult patients with non-small cell lung cancer     

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 30 October, approved the medicine sugemalimab (Eqjubi) to treat adult patients with a type of lung cancer called ‘non-small cell lung cancer’. 

Read the original advice at Foreign Travel Advice (UK)